CELG Stock Recent News Celgene Corp (CELG) 106.45 11/09/2014

New Post Public Reply Private Reply Replies (0) Message Board

Nov 9, 2014 at 11:12 AM

Celgene Corp (CELG) 106.45 $CELG

5 Prescription Drugs Selling Like Hot Cakes
Todd Campbell, The Motley Fool - Motley Fool - 1 hr 10 mins ago
Considering that 90% of prescription drugs being developed by biotechnology companies will fail during clinical trials, it can be tough to know which biotech stocks to seize upon and which stocks to shun. Instead of focusing on unproven...
MDVN: 112.77 (+7.82), JNJ: 108.20 (-0.81), BIIB: 320.75 (-2.72), PTLA: 27.39 (-0.33), GILD: 106.45 (-0.49), CELG: 106.45 (-0.69)

Final Glance: Biotechnology companies
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:
GILD: 106.45 (-0.49), AMGN: 160.25 (-0.10), CELG: 106.45 (-0.69)

Ride The Smart-Money Coattails: Use IBD's Funds Pages
at Investor's Business Daily - Fri Nov 07, 3:10PM CST
Selecting stocks that have superior profit and sales growth is not the sole key to success in the market. Neither is simply buying stocks with outstanding price strength. Before you invest in a stock, make sure that it also is a favorite among the...
AGN: 196.00 (-1.40), HCA: 65.75 (-3.22), BIDU: 236.54 (-0.36), ZBRA: 72.59 (-1.29), SWKS: 59.88 (-2.26), ALK: 55.14 (-0.26), CELG: 106.45 (-0.69)

Pharmacyclics, Inc.'s Imbruvica Holds Its Own Against Gilead Sciences, Inc.'s Zydelig
Todd Campbell, The Motley Fool - Motley Fool - Fri Nov 07, 12:42PM CST
Source: Pharmacyclics Peak sales forecasts for Pharmacyclics' Imbruvica are estimated north of $3 billion, but investors had reason for pause last quarter when competitor Gilead Sciences launched Zydelig for the same indication. ...
JNJ: 108.20 (-0.81), PCYC: 133.49 (-3.63), GILD: 106.45 (-0.49), AZN: 72.88 (+0.03), GSK: 44.91 (+0.16), BMY: 58.32 (-0.14), CELG: 106.45 (-0.69)

Midday Glance: Biotechnology companies
AP - Fri Nov 07, 12:18PM CST
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
GILD: 106.45 (-0.49), AMGN: 160.25 (-0.10), CELG: 106.45 (-0.69)

Early Glance: Biotechnology companies
AP - Fri Nov 07, 9:53AM CST
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
GILD: 106.45 (-0.49), AMGN: 160.25 (-0.10), CELG: 106.45 (-0.69)

Data from More Than 160 Abstracts Highlighting Celgene Therapies to Be Presented at American Society of Hematology Annual Meeting (ASH)
Business Wire - Thu Nov 06, 4:30PM CST
Celgene Corporation (NASDAQ:CELG) today announced that data from more than 160 abstracts, including 39 oral presentations, evaluating Celgene investigational products and investigational uses of marketed products will be presented at the 56th American Society of Hematology Annual Meeting between Dec. 6-9 in San Francisco, Calif.
CELG: 106.45 (-0.69), CELGZ: 3.24 (-0.04)

Will Agios (AGIO) Disappoint in the Q3 Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 4:10PM CST
Agios (AGIO), which is scheduled to report third-quarter results on Nov 7, had delivered a negative earnings surprise of 14.89% in the last quarter.
MNK: 91.06 (-3.49), RNA: 12.14 (+0.08), AGIO: 72.06 (-11.03), CELG: 106.45 (-0.69)

Why Celgene Corporation Stock Rocketed 13% Higher in October
Sean Williams, The Motley Fool - Motley Fool - Thu Nov 06, 7:07AM CST
CELG data by YCharts What: Shares of biopharmaceutical giant Celgene rocketed higher by 13% in October, based on data provided by S&P Capital IQ , after the company reported better-than-expected third-quarter earnings results and...
CELG: 106.45 (-0.69)

Uptrend Call Working As Celgene Stock Rises 11.2% (CELG)
Comtex SmarTrend(R) - Wed Nov 05, 5:19PM CST
SmarTrend identified an Uptrend for Celgene (NASDAQ:CELG) on October 21st, 2014 at $94.56. In approximately 2 weeks, Celgene has returned 11.20% as of today's recent price of $105.15.
CELG: 106.45 (-0.69)

Let Major Indexes Dictate Buy, Sell Decisions
at Investor's Business Daily - Wed Nov 05, 5:01PM CST
The S&P 500 and Nasdaq composite serve as guideposts to the market's health. Ignore them at your own peril. Every day, IBD analyzes the action of these major stock averages to determine whether the market is in an uptrend (healthy) or a correction...
LCI: 50.17 (-0.82), AKRX: 36.59 (-1.29), ORLY: 179.00 (-0.61), AFSI: 49.89 (-0.58), CELG: 106.45 (-0.69)

Critical Alerts For Alibaba, Bloomin' Brands, VoxelJet, 51job and Celgene Released By InvestorsObserver
PR Newswire - Wed Nov 05, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for BABA, BLMN, VJET, JOBS and CELG.
JOBS: 34.06 (+1.66), VJET: 12.33 (-0.61), BLMN: 21.69 (-0.18), CELG: 106.45 (-0.69), BABA: 114.56 (+2.99)

5 Things Celgene Corporation's Management Wants You to Know
Sean Williams, The Motley Fool - Motley Fool - Wed Nov 05, 6:51AM CST
Source: U.S. Department of Agriculture via Flickr . Following another successful quarterly report, investors and shareholders of Celgene have to be wondering if anything can stop this stock from heading higher . For the quarter, Celgene...
OMED: 20.19 (-0.02), AMGN: 160.25 (-0.10), ABBV: 61.50 (-1.21), CELG: 106.45 (-0.69)

These 5 Drugmakers' Earnings Excelled This Quarter
at Investor's Business Daily - Tue Nov 04, 7:14PM CST
Big pharma firms such as Alexion Pharmaceuticals and Biogen Idec continue to outperform the market as they develop and market new treatments to treat long-time targets such as Alzheimer's as well as rare illnesses. Today's Screen Of The Day is Big...
AGN: 196.00 (-1.40), BIIB: 320.75 (-2.72), VRX: 126.11 (-2.66), ACT: 245.91 (-4.47), JAZZ: 170.80 (-1.57), ALXN: 193.81 (+0.67), CELG: 106.45 (-0.69)

Top Funds Buy Ulta Beauty, Alexion, Avago
at Investor's Business Daily - Tue Nov 04, 5:52PM CST
Managers of leading mutual funds in recent months have continued to stock up on large medical stocks, such as Illumina (ILMN), Alexion Pharmaceuticals (ALXN), Celgene (CELG), Jazz Pharmaceuticals (JAZZ),Allergan (AGN) and Centene (CNC). The...
AMBA: 47.14 (+1.13), MNST: 108.39 (+7.91), SWKS: 59.88 (-2.26), GMCR: 152.90 (-0.16), ILMN: 186.35 (-3.52), WSM: 65.88 (-0.05), NXPI: 73.54 (+0.07), CELG: 106.45 (-0.69), HAIN: 107.68 (-0.16), AGN: 196.00 (-1.40), CNC: 91.72 (-1.84), V: 252.43 (+2.34), CALM: 43.03 (-0.09), JAZZ: 170.80 (-1.57), ALXN: 193.81 (+0.67), LOW: 57.69 (+0.12), ULTA: 121.75 (-0.33), MA: 84.80 (-0.95), AVGO: 85.04 (-2.59), PETM: 72.54 (+0.90)

Next Support Level for Celgene (CELG) is $105.49
Comtex SmarTrend(R) - Tue Nov 04, 12:59PM CST
Shares of Celgene (NASDAQ:CELG) have bearishly opened below the pivot of $107.01 today and have reached the first support level of $106.45. Should the shares continue to fall, the support pivots of $105.49 and $103.97 will be of interest.
CELG: 106.45 (-0.69)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Eve Air Mobility's Vector System Proves Its Worth

Eve Air Mobility's Vector system just pulled off something impressive at the Interlagos Circuit, showing it's not just a buzzword in the urban air mobility sphere. Picture this—over 100 helicopter flights in a day, all managed smoothly during one of the biggest motorsport events. That's the kind of action that gets investors to sit up and take notice of NYSE:EVEX....

Custom Upholstered Furniture: Comfort Built to Last

Rethinking Furniture Comfort: Not Just a Luxury Diving into the world of custom upholstered furniture with insights from Randy Marohn is like finding a cheat sheet for comfort. Seriously, it ain't just about plush cushions or slick fabrics—it's a bonafide science. Marohn, from Sans Furniture Inc. in good ol’ Hamburg, NY, unfolds a tale of intentional design and...

TagMaster To Acquire Kapsch's RFID Ops in NA Market

A Strategic Move in the Transportation Sector Here's a fresh shake-up for the North American transportation sector: TagMaster, alongside its U.S. subsidiary Sensys Networks, is all set to acquire Kapsch TrafficCom's RFID-focused North American components business. This isn't just a minor shuffle—this deal could ripple through the industry, promising strategic uplifts...

First-Time Clermont Homebuyers Face Unexpected Hurdles

Welcome to the Wild Ride of Buying a Home! When folks step into the homebuying ring, especially in places like Clermont, Florida, they often don't realize how chaotic things can get. It's like being thrown into a boxing match without gloves. Brandie Mathison-Klein from the Mathison-Klein Group shines a light on this in a HelloNation piece, spilling the beans on what...

Betterness Expands Health Networks with $3.5M Boost

Defining a Health Revolution in the Heart of Miami Just when you think the fitness tech scene might be settling into its groove, along comes Betterness, Inc., shaking things up with another cool million in their pockets. I'm talking about their recent addition to their seed round, now sitting pretty at a robust $3.5 million. You can't ignore how they're taking a...

Monotype's Inkwell: A Type Family with New Twists

Fresh Faces in the World of Type Out of the design trenches comes news that Monotype—the big cheese in type and tech—just rolled out four new styles in its well-liked Inkwell lineup. We're talking Inkwell Antique, Formal, Chancery, and Ornaments here. The idea? Give designers more room to play with tone. Let's chew on what this expansion means for folks rocking...

NueSynergy Secures Top Spot in HSA Provider Rankings

NueSynergy Earns its Stripes in 2026 It seems these days, healthcare costs are rising faster than you can say 'deductible.' In this chaotic landscape, a good HSA provider is worth its weight in gold. Enter NueSynergy, whose efforts have once again been acknowledged by Morningstar, a big name in the world of investment research. What Sets NueSynergy Apart? NueSynergy isn't...

Navigating IRS Notices: CPA Morones' Key Steps

When the IRS Knocks: Don't Panic, Get Organized Picture this, you head home after a grinding day only to find a letter from the IRS lurking in your mailbox. For taxpayers in Southwest New Mexico, as CPA Mike Morones out of Silver City puts it, the blood pressure spikes are real. But as Morones assures, most of these letters don't signal doomsday scenarios. Instead,...

Biointron's RushDATA™: Speeding Up Antibody Discovery

A New Chapter in Antibody Discovery Well, color me intrigued. Biointron, a name you'd recognize if you've got even a toe in the biotech pond, just threw a serious curveball into the antibody discovery game with RushDATA™—an AI- and machine learning-driven platform that's packing a punch. And it's not just about throwing tech buzzwords around; this thing clocks...

Optikos Secures CMMC Level 2, Eyeing Defense Market

Optikos Levels Up with CMMC Certification In a world where cybersecurity threats are lurking around every corner, Optikos has just joined the rarefied ranks of the top 1% of U.S. defense suppliers by grabbing the CMMC Level 2 certification. Let me tell you, this isn't just some shiny badge for show; it's a gateway to big defense contracts. Crunching the Numbers Of the...